Премини към основното съдържание
Home
language-selector-globe Bulgaria | bg
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Bulgaria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • За нас 
      • Новартис в България 
      • Нашата стратегия 
        • Иновативни лекарства 
      • Хора и Култура 
      • Контакти 
      За нас За нас
    • Пациенти и болногледачи 
      • Аз само да попитам: твоят здравен консултант 
      • Ангажиментът на Новартис към пациентите и лицата, които се грижат за тях 
      • Съобщаване на нежелани реакции 
      • Аз само да попитам: твоят здравен портал 
      Пациенти и болногледачи Пациенти и болногледачи
    • Здравни специалисти 
      • Материали за здравни специалисти 
      • Новартис проекти 
      • Съобщаване на нежелани реакции 
      • Клинични проучвания на Новартис 
      Здравни специалисти Здравни специалисти
    • ESG 
      • Етика, Риск и Законосъобразност 
      • Разширяване на достъпа до здравеопазване 
      • Опазване на природата 
      • Световно здраве 
      • Етично поведение 
        • Етичен кодекс 
        • SpeakUp 
      Околна среда, социални и правни въпроси ESG
    • Новини 
      • Медийни контакти 
      • Новини 
      Новини Новини
    • Кариера 
      • Търсене на кариера 
      • Награди и признание 
      Кариера Кариера
    • Коронавирус 
      Коронавирус Коронавирус
    Новартис България Начало
  1. Начало
  2. Кариера
  3. Търсене на кариера
  • Sort by Sort ascending
  • Длъжност Sort descending
  • Място
  • Местоположение
  • дивизия
  • Бизнес
  • Functional Area
  • Дата
Длъжност Sort descending Място Местоположение дивизия Бизнес Functional Area Дата
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - US Commercial Analytics Hyderabad (Office) India Operations CTS Marketing Окт. 21, 2024
Analyst – Patient Oriented Programs Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Окт. 10, 2024
Analyst Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 20, 2024
Analyst Social Media Listening Hyderabad (Office) India Operations CTS Marketing Окт. 22, 2024
Analyst Stratégique H/F) en Stage Rueil-Malmaison France International Innovative Medicines Others Авг. 19, 2024
Analytical Expert – Trace Level Analytics (m/f/d) Basel (City) Switzerland Development Innovative Medicines Research & Development Окт. 25, 2024
Analytical Expert (Associate Director, Science & Technology) Basel (City) Switzerland Development Innovative Medicines Research & Development Окт. 10, 2024
APPRENTI(E) ANIMATEUR SSE (H/F) Huningue France Operations Innovative Medicines Others Юни 10, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue France Operations Innovative Medicines Others Май 31, 2024
Area Marketing Manager Chengdu (Sichuan Province) China International Innovative Medicines Marketing Апр. 30, 2024
Area Marketing Manager Wuhan (Hubei Province) China International Innovative Medicines Marketing Май 06, 2024
AS&T ekspert (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Септ. 09, 2024
AS&T Expert Schaftenau Austria Operations Innovative Medicines Quality Окт. 14, 2024
AS&T Expert Schaftenau Austria Operations Innovative Medicines Quality Окт. 24, 2024
AS&T Expert - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
AS&T Expert (Micro) Tuas South Avenue Singapore Operations Innovative Medicines Quality Окт. 01, 2024
AS&T Hub Team Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Септ. 03, 2024
AS&T Specialist İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Септ. 03, 2024
AS&T Specialist Schaftenau Austria Operations Innovative Medicines Quality Окт. 24, 2024
AS&T Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
AS&T specialist (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Quality Окт. 23, 2024
AS&T specialist (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Quality Окт. 23, 2024
AS&T specialist (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Окт. 17, 2024
ASCVD Brand Manager Seoul South Korea International Innovative Medicines Marketing Септ. 03, 2024
Asset Strategy Lead - Automation (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Окт. 14, 2024
Asset Strategy Lead - Biologics Analysis (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Септ. 27, 2024
Asset Strategy Lead – Automation Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Септ. 27, 2024
Asset Strategy Lead – Biologics Analysis Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Септ. 27, 2024
Assistant(e) de Coordination Accès au Marché H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Market Access Окт. 22, 2024
Assistant(e) de Coordination Senior H/F CDD Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Facilities & Administration Септ. 23, 2024
Assoc Director - Service Management (ITIL , ITSM - Salesforce) Hyderabad (Office) India Operations CTS Technology Transformation Окт. 15, 2024
Assoc. Dir Content Engineering(Azure -AWS-Application management Documentum) Hyderabad (Office) India Operations CTS Technology Transformation Септ. 03, 2024
Assoc. Dir. DDIT APD CE Service Mgmt. INSURGENTES Mexico Operations CTS Technology Transformation Окт. 18, 2024
Assoc. Dir. DDIT APD ERP Commercials and Cross Functional Santo Amaro Brazil Operations CTS Technology Transformation Септ. 03, 2024
Assoc. Dir. DDIT APD ERP PlatformTech Se Hyderabad (Office) India Operations CTS Technology Transformation Май 09, 2024
Assoc. Dir. DDIT Dev. Business Analyst, Global Clinical Operations Barcelona Gran Vía Spain Operations CTS Technology Transformation Авг. 21, 2024
Assoc. Dir. DDIT Dev. GCO Tech. Design (Technical Business Analyst) Hyderabad (Office) India Operations CTS Technology Transformation Авг. 05, 2024
Assoc. Dir. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Окт. 11, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 42
  • › Next page

Новартис България

Навигация
  • Пациенти и болногледачи
  • Здравни специалисти
  • ESG
  • Новини
  • Кариера
Медиен център
  • Архив
  • Новини
Нашето портфолио
  • Клинични проекти на Новартис
Други сайтове на Новартис
  • Глобален сайт
Footer Bottom
© 2024 Новартис АГ
  • Политика за поверителност
  • Условия на ползване
  • Достъп от мрежата
  • Настройки за бисквитки
  • Навигация на сайта
Директория на сайта на Новартис
Тази страница е предназначена за обществеността в България